World Health Organization

Early-Stage Respiratory Syncytial Virus (RSV) Vaccine Trial Begins

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has launched a clinical trial of an investigational vaccine designed to protect against respiratory syncytial virus (RSV). The Phase 1 study will enroll… Read More ›